Latest Housing News

Peninsula Energy expects to book an approximately US$50 million non-cash impairment against legacy assets at its Lance uranium project in Wyoming. The charge removes value from Mine Units 1, 2 and 3 as the company concentrates capital and technical resources on Mine Unit 4 and future development.

Stakk says recurring contracts now support 100% of its approximately A$55.2 million FY2027 pro-forma revenue forecast, while fresh international wins are being built into the FY2028 growth story. The company will establish Singapore as its non-US commercial, service and technology hub from November 2026.

News Corp has reported record fiscal 2026 revenue of $9 billion, with Total Segment EBITDA exceeding $1.6 billion and free cash flow reaching $811 million. Dow Jones and digital real estate services led the performance, while the company returned $643 million through share buybacks.

Katana Capital Limited (ASX:KAT) delivered a 17.98% gross investment return in FY2026, beating the All Ordinaries by 15.55 percentage points as its portfolio benefited from defence, infrastructure, resources and technology exposures. Net profit rose to $3.808 million, while the listed investment company entered FY2027 with elevated cash and a deliberately cautious stance on banks.

Finbar Group (ASX:FRI) delivered its strongest annual profit since FY2015, with net profit rising 40.9% to $20.3 million despite lower revenue. Record pre-sales, reduced debt and a $1.95 billion development pipeline give the Perth apartment developer a substantial FY27 workload.

Michael Hill International has returned to profit growth and restored its dividend after a year of sharper execution, brand simplification and stronger cash generation. Record revenue and a 57% rise in comparable EBIT mark a meaningful recovery, although the reset remains unfinished.

MyState delivered a sharp rise in FY26 profit as Auswide integration produced $11.8 million in run-rate synergies, while the group lifted its full-year dividend to 24.5 cents per share. The next test is turning early integration gains into a larger payoff without losing control of technology costs and credit risk.

Ceretas has completed the third milestone of its government-backed CUREator+ program, unlocking a final $692,578 non-dilutive funding tranche. The work delivered functional prototypes of proprietary neuronavigation software and a lift assist device intended to simplify operation of its next-generation Alzheimer’s ultrasound system.

Silver Mines says NSW planning authorities have reaffirmed that the Bowdens Silver Project is in the public interest and approvable subject to strict conditions. The Independent Planning Commission will resume its public hearing in October, with a final decision expected by 9 December 2026.

James Hardie has raised its FY27 Free Cash Flow target to at least US$600 million and expects to deliver its US$125 million cost synergy target roughly a year early. The company also outlined a 4% to 7% annual organic growth ambition above market, while targeting net leverage below 2.0x by Q2 FY28.

Imagion Biosystems has signed nanoComposix to resume GMP-aligned manufacturing of the MagSense nanoparticle core, a move designed to support its FDA-cleared HER2 breast cancer programme without the fixed cost of an in-house facility. The agreement improves manufacturing readiness, but its value, duration and production commitments remain undisclosed.

Barramundi’s portfolio surged in August, delivering a 6.7% adjusted NAV return against a 1.9% benchmark gain. The recovery leaves the NZX-listed investment company trading at a 13.2% discount to its underlying portfolio value.